Radiopharm Theranostics Limited

RADXNASDAQ Capital Market·USD·Closed

RADXNASDAQ·USD·Closed

$4.40

+1.96%

$4.40

+$0.08 (1.96%)

52W Range

6thpctl

Volume

0.06×avg

Mkt Cap

5.67MUSD

P/E

-1.6TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

6thpctl

Volume

0.06×avg

Market Cap

5.67MUSD

P/E Ratio

-1.6TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+1114.3% / yr

Operating margin-402.8%

ROIC-59.9%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-380.6×

Current ratio3.01×

Continue with finqOS

Unlock the full picture

SEC filings, earnings transcripts, insider trades, institutional ownership, 175+ screening metrics, and an infinite research canvas.

14-day free trial · No credit card required